People · Operator
Named in public records as an officer, director or promoter · active 2020–2025 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| TuHURA Biosciences, Inc./NV | — | Biotechnology | Series B | $41.6M | $6.1M | 2025 |
| Morphogenesis Inc | — | Biotechnology | Series B | $27.9M | $15.1M | 2020 |
| Calidi Biotherapeutics, Inc. | — | Biotechnology | Series A | $15.2M | $30.2M | 2023 |
| Ggwp, Inc. | — | Other Technology | Series A | $12.0M | $268.1M | 2021 |
George Ng at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside George Ng on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Manuso | 2 | 4 |
| James Bianco | 2 | 4 |
| Dan Dearborn | 2 | 2 |
| Alan List | 2 | 2 |
| Robert Hoffman | 1 | 5 |
| Dennis Brown | 1 | 5 |
| Alan R. Stewart | 1 | 4 |
| Andrew Jackson | 1 | 4 |
| Keith Murphy | 1 | 4 |
| SAIID ZARRABIAN | 1 | 3 |
| James A. Schoeneck | 1 | 3 |
| WILLIAM GARNER | 1 | 2 |
| Kun Gao | 1 | 2 |
| Laura Johnson | 1 | 2 |
| John K. Bell | 1 | 2 |
| Jeffrey Bacha | 1 | 2 |
| Alfonso F. Zulueta | 1 | 1 |
| James F. Schoeneck | 1 | 1 |
| Heehyoung F. Lee | 1 | 1 |
| Allan Camaisa | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.